Search research articles
Contact Us
Filters
Showing results (141-150 of 216) with videos related to
Page
of 22
Sort By:
ESC Heart Failure
|
February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan
Frank L Dini, Erberto Carluccio, Roberto Bitto, et al.
European Heart Journal
|
February 25, 2026
Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registry
Lars H Lund, Aldo P Maggioni, Maria G Crespo-Leiro, et al.
International Journal of Cardiology
|
January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study
Erberto Carluccio, Frank L Dini, Roberto Bitto, et al.
Giornale Italiano Di Cardiologia (2006)
|
October 25, 2018
[Cardiac rehabilitation "3.0": from the acute to the chronic stage. A position paper from the Italian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)]
Roberto F E Pedretti, Francesco Fattirolli, Raffaele Griffo, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
October 31, 2018
Cardiac Prevention and Rehabilitation "3.0": From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)
Roberto F E Pedretti, Francesco Fattirolli, Raffaele Griffo, et al.
International Journal of Cardiology
|
November 7, 2025
Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD)
Antonia Camporeale, Giada De Angeli, Gianluigi Guida, et al.
European Journal of Preventive Cardiology
|
October 27, 2023
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset
Damiano Magrì, Giovanna Gallo, Massimo Piepoli, et al.
European Journal of Heart Failure
|
June 17, 2025
The European heart failure management resources, treatment reimbursement and activities of professional and patient organizations
Petar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 21, 2026
Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial
Xavier Rossello, José A Barrabés, Massimo Piepoli, et al.
European Journal of Heart Failure
|
May 30, 2025
Insights into the European heart failure epidemiology
Petar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 216) with videos related to
Sort By:
Page
of 22
ESC Heart Failure
|
February 5, 2022
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan
Frank L Dini, Erberto Carluccio, Roberto Bitto, et al.
European Heart Journal
|
February 25, 2026
Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registry
Lars H Lund, Aldo P Maggioni, Maria G Crespo-Leiro, et al.
International Journal of Cardiology
|
January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study
Erberto Carluccio, Frank L Dini, Roberto Bitto, et al.
Giornale Italiano Di Cardiologia (2006)
|
October 25, 2018
[Cardiac rehabilitation "3.0": from the acute to the chronic stage. A position paper from the Italian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)]
Roberto F E Pedretti, Francesco Fattirolli, Raffaele Griffo, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
October 31, 2018
Cardiac Prevention and Rehabilitation "3.0": From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)
Roberto F E Pedretti, Francesco Fattirolli, Raffaele Griffo, et al.
International Journal of Cardiology
|
November 7, 2025
Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD)
Antonia Camporeale, Giada De Angeli, Gianluigi Guida, et al.
European Journal of Preventive Cardiology
|
October 27, 2023
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset
Damiano Magrì, Giovanna Gallo, Massimo Piepoli, et al.
European Journal of Heart Failure
|
June 17, 2025
The European heart failure management resources, treatment reimbursement and activities of professional and patient organizations
Petar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 21, 2026
Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial
Xavier Rossello, José A Barrabés, Massimo Piepoli, et al.
European Journal of Heart Failure
|
May 30, 2025
Insights into the European heart failure epidemiology
Petar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
Page
of 22